Evidence map›Paper›PMID 37358661›Full record

ReviewBrain structure & function2023

Analyzing the Virchow pioneering report on brain corpora amylacea: shedding light on recurrent controversies.

Marta Riba, Clara Romera, Raquel Alsina, Gerard Alsina-Scheer, Carme Pelegrí, Jordi Vilaplana, Jaume Del Valle

Open access · hybridAbstract readReview
In one paragraph

Review in Brain structure & function, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marta RibaSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0001-6293-9791
Clara RomeraSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0002-8233-9838
Raquel AlsinaSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4095-1703
Gerard Alsina-Scheer, Barcelona, Spain.
Carme PelegríSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7734-1546
Jordi VilaplanaSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain.ORCID http://orcid.org/0000-0003-2113-238X
Jaume Del ValleSecció de Fisiologia, Departament de Bioquímica i Fisiologia, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08028, Barcelona, Spain. jdelvalle@ub.edu.ORCID http://orcid.org/0000-0002-6703-8244
Biomedical Research Networking Center on Neurodegenerative Diseases · ES

Funding

Generalitat de Catalunya 2017/SGR625Ministerio de Ciencia e Innovación PID2020-115475GB-I00/AEI/10.13039/501100011033Ministerio de Universidades Margarita Salas
6 · The paper itself

Abstract

The first report of corpora amylacea (CA) is attributed to Morgagni, who described them in the prostate in the eighteenth century. Nearly a hundred years later, and following the lead started by Purkinje, Virchow described them in the brain. He made a detailed description of the most useful techniques to visualize them, but he failed to describe the cause of why CA do appear, why they are mainly linked with the elderly, and which is their clinical significance. Although in the last two centuries CA have received little attention, recent data have been able to describe that CA accumulate waste products and that some of them can be found in the cerebrospinal fluid and lymphatic nodes, after being released from the brain. Indeed, CA have been renamed to wasteosomes to underline the waste products they gather and to avoid confusion with the term amyloid used by Virchow, now widely related to certain protein deposits found in the brain. Here, after providing a commented English translation of Virchow's findings, we provide a recent update on these structures and their connection with the glymphatic system insufficiency, for which wasteosomes should be considered a hallmark, and how these bodies could serve as diagnostic or prognostic markers of various brain conditions.

Indexed as

BrainBrain DiseasesAgedAmyloidHumansMaleWaste ProductsAmyloidWaste ProductsBrainChronic glymphatic insufficiencyCorpora amylaceaGlymphatic systemNeoepitopesWasteosomes

Identifiers

PMID37358661
PMCPMC10335943
OpenAlexW4382010524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.